CEN/TC 206
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 38319 | EN ISO 10993-6:2016 | Biological evaluation of medical devices - Part 6: Tests for local effects after implantation (ISO 10993-6:2016) | Atcelts |
| 9499 | EN ISO 10993-17:2002 | Biological evaluation of medical devices - Part 17: Establishment of allowable limits for leachable substances (ISO 10993-17:2002) | Atcelts |
| 9496 | EN ISO 10993-4:2002 | Biological evaluation of medical devices - Part 4: Selection of tests for interactions with blood (ISO 10993-4:2002) | Atcelts |
| 9494 | EN ISO 10993-16:1997 | Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables (ISO 10993-16:1997) | Atcelts |
| 32002 | EN ISO 10993-16:2009 | Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables (ISO 10993-16:1997) | Atcelts |
| 60721 | LVS EN ISO 10993-1:2021 | Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process (ISO 10993-1:2018, including corrected version 2018-11) | Atcelts |
| 62983 | LVS EN ISO 14155:2020 | Clinical investigation of medical devices for human subjects - Good clinical practice (ISO 14155:2020) | Atcelts |
| 79539 | LVS EN ISO 14155:2020/A11:2024 | Clinical investigation of medical devices for human subjects - Good clinical practice | Atcelts |
| 9493 | LVS EN ISO 10993-7:2009 | Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals (ISO 10993-7:2008) | Atcelts |
| 64034 | LVS EN ISO 10993-7:2009/A1:2022 | Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals - Amendment 1: Applicability of allowable limits for neonates and infants (ISO 10993-7:2008/Amd 1:2019) | Atcelts |
Displaying 161-170 of 200 results.